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ABSTRACT
Motivation: Predicting interactions between small molecules and
proteins is a crucial step to decipher many biological processes, and
plays a critical role in drug discovery. When no detailed 3D structure
of the protein target is available, ligand-based virtual screening allows
the construction of predictive models by learning to discriminate
known ligands from non-ligands. However, the accuracy of ligand-
based models quickly degrades when the number of known ligands
decreases, and in particular the approach is not applicable for orphan
receptors with no known ligand.
Results: We propose a systematic method to predict ligand–protein
interactions, even for targets with no known 3D structure and few
or no known ligands. Following the recent chemogenomics trend,
we adopt a cross-target view and attempt to screen the chemical
space against whole families of proteins simultaneously. The lack
of known ligand for a given target can then be compensated by
the availability of known ligands for similar targets. We test this
strategy on three important classes of drug targets, namely enzymes,
G-protein-coupled receptors (GPCR) and ion channels, and report
dramatic improvements in prediction accuracy over classical ligand-
based virtual screening, in particular for targets with few or no known
ligands.
Availability: All data and algorithms are available as Supplementary
Material.
Contact: laurent.jacob@ensmp.fr
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Predicting interactions between small molecules and proteins is a
key element in the drug discovery process. In particular, several
classes of proteins such as G-protein-coupled receptors (GPCR),
enzymes and ion channels represent a large fraction of current drug
targets and important targets for new drug development (Hopkins
and Groom, 2002). Understanding and predicting the interactions
between small molecules and such proteins could therefore help in
the discovery of new lead compounds.
Variousapproacheshavealreadybeendevelopedandhaveproved
very useful to address this in silico prediction issue (Manly et al.,
2001).The classical paradigm is to predict the modulators of a given
∗To whom correspondence should be addressed.
target, considering each target independently from other proteins.
Usual methods are classiﬁed into ligand-based and structure-
based or docking approaches. Ligand-based approaches compare
a candidate ligand to the known ligands of the target to make
theirprediction,typicallyusingmachinelearningalgorithms(Butina
et al., 2002; Byvatov et al., 2003) whereas structure-based
approaches use the 3D-structure of the target to determine how well
each candidate binds the target (Halperin et al., 2002).
Ligand-based approaches require the knowledge of sufﬁcient
ligands of a given target with respect to the complexity of the
ligand/non-ligand separation to produce accurate predictors. If few
or no ligands are known for a target, one is compelled to use docking
approaches, which in turn require the 3D structure of the target and
are very time consuming. If for a given target with unavailable 3D
structure no ligand is known, none of the classical approaches can
be applied. This is the case for many GPCR as very few structures
have been crystallized so far (Ballesteros and Palczewski, 2001)
and many of these receptors, referred to as orphan GPCR, have no
known ligand.
An interesting idea to overcome this issue is to stop considering
each protein target independently from other proteins, and rather
take the point of view of chemogenomics (Jaroch and Weinmann,
2006; Kubinyi et al., 2004). Roughly speaking, chemogenomics
aims at mining the entire chemical space, which corresponds to the
set of all small molecules, for interactions with the biological space,
i.e. the set of all proteins or at least protein families, in particular
drug targets. A salient motivation of the chemogenomics approach
is the realization that some classes of molecules can bind ‘similar’
proteins, suggesting that the knowledge of some ligands for a target
can be helpful to determine ligands for similar targets. Besides,
this type of method allows for a more rational approach to design
drugs since controlling a whole ligand’s selectivity proﬁle is crucial
to make sure that no side effect occurs and that the compound is
compatible with therapeutical usage.
Recent reviews (Jaroch and Weinmann, 2006; Klabunde, 2007;
Kubinyietal.,2004;Rognan,2007)describeseveralchemogenomic
approaches to predict interactions between compounds and targets.
A ﬁrst class of approaches, called ligand-based chemogenomics
by Rognan (2007), pool together targets at the level of families
(such as GPCR) or subfamilies (such as purinergic GPCR) and
learn a model for ligands at the level of the family (Balakin et al.,
2002; Klabunde, 2006). Other approaches, termed target-based
chemogenomic approaches by Rognan (2007), cluster receptors
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based on ligand binding site similarity and again pool together
known ligands for each cluster to infer shared ligands (Frimurer
et al., 2005). Finally, a third strategy termed target-ligand approach
by Rognan (2007) attempts to predict ligands for a given target
by leveraging binding information for other targets in a single
step, that is, without ﬁrst attempting to deﬁne a particular set
of similar receptors. For example, Bock and Gough (2005)
merge descriptors of ligands and targets to describe putative
ligand–receptor complexes, and use machine learning methods to
discriminate real complexes from ligand–receptor pairs that do not
form complexes. Erhan et al. (2006) show how the same idea can
be casted in the framework of neural networks and support vector
machines(SVM).Inparticular,theyshowthatagivensetofreceptor
descriptors can be combined with a given set of ligand descriptors in
a computationally efﬁcient framework, offering in principle a large
ﬂexibility in the choice of the receptor and ligand descriptors.
In this article, we go one step further in this direction and
investigate various kinds of receptor and ligand descriptors that can
be combined for in silico chemogenomics screening with SVM,
building on recent development in the ﬁeld of kernel methods for
bio- and chemoinformatics. In particular, we propose a new kernel
for receptors, based on a priori deﬁned hierarchies of receptors.
We test the different methods for the prediction of ligands for
three major classes of therapeutic targets, namely enzymes, GPCR
and ion channels. We show that the choice of representation
has a strong inﬂuence on the accuracy of the model estimated,
and in particular that the new hierarchy kernel systematically
outperformsotherdescriptorsusedinmultitasklearningorinvolving
receptor sequences. We show that the chemogenomics approach
is, particularly, relevant for targets with few known ligands. In
particular we estimate that, for orphan receptors with no known
ligands,ourmethodreachesanormalizedaccuracyof86.2%,77.6%
and 80.5% on the enzymes, GPCR and ion channels, respectively,
well above the 50% accuracy of a random predictor that would be
trained in a classical ligand-based virtual screening framework with
no training example.
2 METHOD
We formulate the typical in silico chemogenomics problem as the
following learning problem: given a collection of n target/molecule pairs
(t1,c1),...,(tn,cn) known to form complexes or not, estimate a function
f(t,c) that would predict whether any chemical c binds to any target t.I n
this section, we propose a rigorous and general framework to solve this
problems building on recent developments of kernel methods in bio- and
chemoinformatics. This approach is similar to the approaches proposed in
the context of MHC-I-peptide binding prediction (Jacob and Vert, 2008) and
in (Erhan et al., 2006).
2.1 From single-target screening to chemogenomics
Much effort in chemoinformatics has been devoted to the more restricted
problem of mining the chemical space for interaction with a single target
t, using a training set of molecules c1,...,cn known to interact or not with
the target. Machine learning approaches, such as artiﬁcial neural networks
(ANN) or SVM, often provide competitive models for such problems. The
simplest linear models start by representing each molecule c by a vector
representation  (c), before estimating a linear function ft(c)=w 
t  (c)
whose sign (positive or negative) is used to predict whether or not the small
molecule c is a ligand of the target t. The weight vector wt is typically
estimated based on its ability to correctly predict the classes of molecules in
the training set.
The in silico chemogenomics problem is more general because data
involving interactions with different targets are available to train a model
which must be able to predict interactions between any molecule and any
protein. In order to extend the previous machine learning approaches to this
setting, we need to represent a pair (t,c) of target t and chemicals c by a
vector  (t,c), then estimate a linear function f(t,c)=w  (t,c) whose sign
is used to predict whether or not c can bind to t. As before the vector w can
be estimated from the training set of interacting and non-interacting pairs,
using any linear machine learning algorithm.
Tosummarize,weproposetocasttheinsilicochemogenomicsproblemas
a learning problem in the ligand–target space thus making it suitable to any
classical linear machine learning approach as soon as a vector representation
 (t,c) is chosen for protein/ligand pairs. We propose in the next sections a
systematic way to design such a representation.
2.2 Vector representation of target/ligand pairs
A large literature in chemoinformatics has been devoted to the problem
of representing a molecule c by a vector  lig(c)∈Rdc, e.g. using various
molecular descriptors (Todeschini and Consonni, 2002). These descriptors
encode several features related to the physicochemical and structural
properties of the molecules, and are widely used to model interactions
betweenthesmallmoleculesandasingletargetusinglinearmodelsdescribed
in the previous section (Gasteiger and Engel, 2003). Similarly, much work
in computational biology has been devoted to the construction of descriptors
for genes and proteins, in order to represent a given protein t by a vector
 tar(t)∈Rdt. The descriptors typically capture properties of the sequence or
structure of the protein, and can be used to infer models to predict, e.g. the
structural or functional class of a protein.
For our in silico chemogenomics problem, we need to represent each pair
(c,t) of small molecule and protein by a single vector  (c,t). In order to
capture interactions between features of the molecule and of the protein that
may be useful predictors for the interaction between c and t, we propose to
consider features for the pair (c,t) obtained by multiplying a descriptor of c
with a descriptor of t. Intuitively, if for example, the descriptors are binary
indicators of speciﬁc structural features in each small molecule and proteins,
then the product of two such features indicates that both the small molecule
and the target carry speciﬁc features, which may be strongly correlated with
the fact that they interact. More generally, if a molecule c is represented
by a vector of descriptors  lig(c)∈Rdc and a target protein by a vector of
descriptors  tar(t)∈Rdt, this suggests to represent the pair (c,t) by the set
of all possible products of features of c and t, i.e. by the tensor product:
 (c,t)= lig(c)⊗ tar(t). (1)
Remember that the tensor product in (1) is a dc×dt vector whose (i,j)-th
entry is exactly the product of the i-th entry of  lig(c)b yt h ej-th entry of
 tar(t). This representation can be used to combine in an algorithmic way
any vector representation of small molecules with any vector representation
of proteins, for the purpose of in silico chemogenomics or any other task
involving pairs of molecules/protein. A potential issue with this approach,
however, is that the size of the vector representation for a pair may be
prohibitively large for practical computation and storage. For example,
using a vector of molecular descriptors of size 1024 for molecules and
representing a protein by the vector of counts of all 2mers of amino acids in
its sequence (dt =20×20=400) results in more than 400k dimensions for
the representation of a pair. In order to circumvent this issue we now show
how kernel methods such as SVM can efﬁciently work in such large spaces.
2.3 Kernels for target/ligand pairs
SVM is an algorithm to estimate linear binary classiﬁers from a training set
of patterns with known class (Boser et al., 1992; Vapnik, 1998). A salient
feature of SVM, often referred to as the kernel trick, is its ability to process
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large- or even inﬁnite-dimensional patterns as soon as the inner product
between any two patterns can be efﬁciently computed. This property is
shared by a large number of popular linear algorithms, collectively referred
to as kernel methods, including for example, algorithms for regression,
clustering or outlier detection (Schölkopf and Smola, 2002; Shawe-Taylor
and Cristianini, 2004).
In order to apply kernel methods such as SVM for in silico
chemogenomics, we therefore need to show how to efﬁciently compute the
inner product between the vector representations of two molecule/protein
pairs. Interestingly, a classical property of tensor products allows us to
factorize the inner product between two tensor product vectors as follows:

 lig(c)⊗ tar(t)
 
 lig(c )⊗ tar(t )

= lig(c)  lig(c )× tar(t)  tar(t ). (2)
This factorization dramatically reduces the burden of working with tensor
products in large dimensions. For example, in our previous example where
the dimensions of the small molecule and proteins are vectors of respective
dimensions 1024 and 400, the inner product in >400k dimensions between
tensorproductsissimplyobtainedfrom(2)bycomputingtwoinnerproducts,
respectively in dimensions 1024 and 400, before taking their product.
Even more interestingly, this reasoning extends to the case where inner
products between vector representations of small molecules and proteins
can themselves be efﬁciently computed with the help of positive deﬁnite
kernels (Vapnik, 1998), as explained in the next sections. Positive deﬁnite
kernels are linked to inner products by a fundamental result (Aronszajn,
1950): the kernel between two points is equivalent to an inner product
between the points mapped to a Hilbert space uniquely deﬁned by the kernel.
Now by denoting
Kligand(c,c )= lig(c)  lig(c ),
Ktarget(t,t )= tar(t)  tar(t ),
we obtain the inner product between tensor products by:
K

(c,t),(c ,t )

=Ktarget(t,t )×Kligand(c,c ). (3)
In summary, as soon as two kernels Kligand and Ktarget corresponding to
twoimplicitembeddingsofthechemicalandbiologicalspacesintwoHilbert
spaces are chosen, we can solve the in silico chemogenomics problem with
an SVM (or any other relevant kernel method) using the product kernel
(3) between pairs. The particular kernels Kligand and Ktarget should ideally
encode properties related to the ability of similar molecules to bind similar
targets or ligands, respectively. We review in the next two sections possible
choices for such kernels.
2.4 Kernels for ligands
Recent years have witnessed impressive advances in the use of SVM in
chemoinformatics (Ivanciuc, 2007). In particular, much work has focused
on the development of kernels for small molecules for the purpose of single-
target virtual screening and prediction of pharmacokinetics and toxicity.
For example, simple inner products between vectors of classical molecular
descriptors have been widely investigated, including physicochemical
properties of molecules or 2D and 3D ﬁngerprints (Azencott et al., 2007;
Todeschini and Consonni, 2002). Other kernels have been designed directly
fromthecomparisonof2Dand3Dstructuresofmolecules,includingkernels
based on the detection of common substructures in the 2D structures of
moleculesseenasgraphs(BorgwardtandKriegel,2005;Gärtneretal.,2003;
Horváthetal.,2004;Kashimaetal.,2003,2004;MahéandVert,2006;Mahé
et al., 2005; Ralaivola et al., 2005) or on the encoding of various properties
of the 3D structure of molecules (Azencott et al., 2007; Mahé et al., 2006).
While any of these kernels could be used to model the similarities of small
molecules and be plugged into (3), we restrict ourselves in our experiment to
a particular kernel proposed by Ralaivola et al. (2005) called the Tanimoto
kernel, a classical choice that usually gives state-of-the-art performances in
molecule classiﬁcation tasks. It is deﬁned as:
Kligand(c,c )
=
 lig(c)  lig(c )
 lig(c)  lig(c)+ lig(c )  lig(c )− lig(c)  lig(c )
, (4)
where lig(c)isabinaryvectorwhosebitsindicatethepresenceorabsenceof
alllinearpathoflengthl orlessassubgraphofthe2Dstructureofc.Wechose
l=8 in our experiment, i.e. characterize the molecules by the occurrences
of linear subgraphs of length 8 or less, a value previously observed to give
good results in several virtual screening task (Mahé et al., 2005). We used
the freely and publicly available ChemCPP1 software to compute this kernel
in the experiments.
2.5 Kernels for targets
SVM and kernel methods are also widely used in bioinformatics (Schölkopf
et al., 2004), and a variety of approaches have been proposed to design
kernels between proteins, ranging from kernels based on the amino-acid
sequence of a protein (Cuturi and Vert, 2005; Jaakkola et al., 2000; Kuang
et al., 2005; Leslie et al., 2002, 2004; Tsuda et al., 2002; Vert et al., 2004)
to kernels based on the 3D structures of proteins (Borgwardt et al., 2005;
Dobson and Doig, 2005; Qiu et al., 2007) or the pattern of occurrences of
proteins in multiple sequenced genomes (Vert, 2002). These kernels have
been used in conjunction with SVM or other kernel methods for various
tasksrelatedtostructuralorfunctionalclassiﬁcationofproteins.Whileanyof
thesekernelscantheoreticallybeusedasatargetkernelin (3),weinvestigate
in this article a restricted list of speciﬁc kernels described below, aimed at
illustrating the ﬂexibility of our framework and test various hypothesis.
• The Dirac kernel between two targets t,t  is:
KDirac(t,t )=

1i f t=t ,
0 otherwise.
(5)
This basic kernel simply represents different targets as orthonormal
vectors. From (3) we see that orthogonality between two proteins t
and t  implies orthogonality between all pairs (c,t) and (c ,t ) for
any two small molecules c and c . This means that a linear classiﬁer
for pairs (c,t) with this kernel decomposes as a set of independent
linear classiﬁers for interactions between molecules and each target
protein, which are trained without sharing any information of known
ligands between different targets. In other words, using Dirac kernel
for proteins amounts to performing classical learning independently
for each target, which is our baseline approach.
• The multitask kernel between two targets t,t  is deﬁned as:
Kmultitask(t,t )=1+KDirac(t,t ).
This kernel, originally proposed in the context of multitask learning
(Evgeniou et al., 2005), removes the orthogonality of different
proteins to allow sharing of information. As explained in Evgeniou
et al. (2005), plugging Kmultitask in (3) amounts to decomposing the
linearfunctionusedtopredictinteractionsasasumofalinearfunction
common to all targets and of a linear function speciﬁc to each target:
f(c,t)=w  (c,t)=w 
general lig(c)+w 
t  lig(c). (6)
A consequence is that only data related to the target t are used to
estimate the speciﬁc vector wt, while all data are used to estimate the
common vector wgeneral. In our framework this classiﬁer is therefore
the combination of a target-speciﬁc part accounting for target-speciﬁc
properties of the ligands and a global part accounting for general
properties of the ligands across the targets. The latter term allows
to share information during the learning process, while the former
ensures that speciﬁcities of the ligands for each target are not lost.
1Available at http://chemcpp.sourceforge.net.
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• While the multitask kernel provides a basic framework to share
information across proteins, it does not allow to weigh differently
how known interactions with a protein t should contribute to predict
interactions with a target t . Empirical observations underlying
chemogenomics, on the other hand, suggest that molecules binding
a ligand t are only likely to bind ligand t  similar to t in terms of
structure or evolutionary history. In terms of kernels this suggest
to plug into (3) a kernel for proteins that quantiﬁes this notion of
similarity between proteins, which can, for example, be detected by
comparing the sequences of proteins. In order to test this approach,
we therefore tested two commonly used kernels between protein
sequences: the mismatch kernel (Leslie et al., 2004), which compares
proteins in terms of common short sequences of amino acids up
to some mismatches, and the local alignment kernel (Vert et al.,
2004)whichmeasuresthesimilaritybetweenproteinsasanalignment
score between their primary sequences. In our experiments involving
the mismatch kernel, we use the classical choice of 3-mers with
a maximum of one mismatch, and for the datasets where some
sequences were not available in the database, we added KDirac(t,t )
to the kernel (and normalized to one on the diagonal) in order to keep
it valid.
• Alternatively, we propose a new kernel aimed at encoding the
similarity of proteins with respect to the ligands they bind.
Indeed, for most major classes of drug targets such as the ones
investigatedinthisstudy(GPCR,enzymesandionchannels),proteins
have been organized into hierarchies that typically describe the
precise functions of the proteins within each family. Enzymes are
labeled with Enzyme Commission numbers (EC numbers) deﬁned
in International Union of Biochemistry and Molecular Biology
(1992), that classify the chemical reaction they catalyze, forming a
four-level hierarchy encoded into four numbers. For example, EC1
includesoxidoreductases,EC1.2includesoxidoreductasesthatacton
the aldehyde or oxo group of donors, EC1.2.2 is a subclass of EC1.2
with NAD+ or NADP+ as acceptor and EC1.2.2.1 is a subgroup of
enzymes catalyzing the oxidation of formate to bicarbonate. These
number deﬁne a natural and very informative hierarchy on enzymes:
one can expect that enzymes that are closer in the hierarchy will
tend to have more similar ligands. Similarly, GPCRs are grouped into
four classes based on sequence homology and functional similarity:
the rhodopsin family (class A), the secretin family (class B), the
metabotropic family (class C) and a last class regrouping more
diverse receptors (class D). The KEGG database (Kanehisa et al.,
2002) subdivides the large rhodopsin family in three subgroups
(amine receptors, peptide receptors and other receptors) and adds
a second level of classiﬁcation based on the type of ligands
or known subdivisions. For example, the rhodopsin family with
amine receptors is subdivided into cholinergic receptors, adrenergic
receptors, etc. This also deﬁnes a natural hierarchy that we could
use to compare GPCRs. Finally, KEGG also provides a classiﬁcation
of ion channels. Classiﬁcation of ion channels is a less simple task
since some of them can be classiﬁed according to different criteria
like voltage dependence or ligand gating. The classiﬁcation proposed
by KEGG includes Cys-loop superfamily, glutamate-gated cation
channels, epithelial and related Na+ channels, voltage-gated cation
channels, related to voltage-gated cation channels, related to inward
rectiﬁer K+ channels, chloride channels and related toATPase-linked
transportersandeachoftheseclassesisfurthersubdividedaccording,
for example to the type of ligands (e.g. glutamate receptor) or to the
type of ion passing through the channel (e.g. Na+ channel). Here
again, this hierarchy can be used to deﬁne a meaningful similarity in
terms of interaction behavior.
For each of the three target families, we deﬁne the hierarchy kernel
between two targets of the family as the number of common ancestors
in the corresponding hierarchy plus one, that is,
Khierarchy(t,t )=  h(t), h(t ) ,
where  h(t) contains as many features as there are nodes in the
hierarchy, each being set to 1 if the corresponding node is part of
t’s hierarchy and 0 otherwise, plus one feature constantly set to
one that accounts for the ‘plus one’ term of the kernel. One might
not expect the EC classiﬁcation to be a good similarity measure in
terms of binding, since it does not closely reﬂect evolutionary or
mechanistic similarities except for the case of identical subclasses
with different serial numbers. However, using the full hierarchy gave
a better accuracy in our experiments. Even if the hierarchy itself is not
fully relevant in this case, the improvement can be explained, on the
one hand, by the multitask effect, i.e. by the fact that we use the data
from the target and the data from other targets with a smaller weight,
and on the other hand, by the fact that we give more weight to the
enzymes with the same serial number than to the other enzymes.
3 DATA
We extracted compound interaction data from the KEGG BRITE
Database (Kanehisa et al., 2002, 2004) concerning enzyme, GPCR
and ion channel, three target classes particularly relevant for novel
drug development.
For each family, the database provides a list of known compounds
for each target. Depending on the target families, various categories
of compounds are deﬁned to indicate the type of interaction between
each target and each compound. These are, for example, inhibitor,
cofactor andeffector forenzymeligands,antagonist or(full/partial)
agonist for GPCR and pore blocker, (positive/negative) allosteric
modulator, agonist or antagonist for ion channels. The list is not
exhaustive for the latter since numerous categories exist. Although
different types of interactions on a given target might correspond
to different binding sites, it is theoretically possible for a non-
linear classiﬁer like SVM with non-linear kernels to learn classes
consisting of several disconnected sets. Therefore, for the sake of
clarityofouranalysis,wedonotdifferentiatebetweenthecategories
of compounds.
For each target class, we retained only one protein by element of
the hierarchy. In particular, we did not take into account the different
orthologs of the targets, and the different enzymes corresponding
to the same EC number. We then eliminated all compounds for
which no molecular descriptor was available (principally peptide
compounds), and all the targets for which no compound was known.
For each target, we generated as many negative ligand–target pairs
as we had known ligands forming positive pairs by combining
the target with a ligand randomly chosen among the other targets’
ligands (excluding those that were known to interact with the given
target). This protocol generates false negative data since some
ligands could actually interact with the target although they have
not been experimentally tested, and our method could beneﬁt from
experimentally conﬁrmed negative pairs.
This resulted in 2436 data points for enzymes (1218
known enzyme–ligand pairs and 1218 generated negative points)
representinginteractionsbetween675enzymesand524compounds,
798 training data points for GPCRs representing interactions
between 100 receptors and 219 compounds and 2330 ion channel
data points representing interactions between 114 channels and 462
compounds. Besides, Figure 1 shows the distribution of the number
of known ligands per target for each dataset and illustrates the fact
that for most of them, few compounds are known.
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Fig. 1. Distribution of the number of training points for a target for the enzymes, GPCR and ion channel datasets. Each bar indicates the proportion of targets
in the family for which a given (x-axis) number of data points is available.
For each target t in each family, we carried out two experiments.
First, all data points corresponding to other targets in the family
were used for training only and the nt points corresponding to t
were k-folded with k=min(nt,10). That is, for each fold, an SVM
classiﬁer was trained on all points involving other targets of the
familyplusafractionofthepointsinvolvingt,thentheperformances
of the classiﬁer were tested on the remaining fraction of data points
for t. This protocol is intended to assess the incidence of using
ligands from other targets on the accuracy of the learned classiﬁer
for a given target. Second, for each target t we trained an SVM
classiﬁer using only interactions that did not involve t and tested on
the points that involved t. This is intended to simulate the behavior
of our framework when making predictions for orphan targets, i.e.
for targets for which no ligand is known.
For both experiments, we used the area under the ROC curve
(AUC) as a performance measure. The ROC curve was computed
for each target using the test points pooled from all the folds. For the
ﬁrst protocol, since training an SVM with only one training point
does not really make sense and can lead to ‘anti-learning’ less than
0.5 performances, we set all results r involving the Dirac target
kernel on targets with only one known ligand to max(r,0.5). This
is to avoid any artifactual penalization of the Dirac approach and
make sure we measure the actual improvement brought by sharing
information across targets.
4 RESULTS
We ﬁrst discuss the results obtained on the three datasets for the
ﬁrst experiment, assessing how using training points from other
targets of the family improves prediction accuracy with respect to
individual (Dirac-based) learning. Table 1 shows the mean AUC
across the family targets for an SVM with a product kernel using
the Tanimoto kernel for ligands and various kernels for proteins.
For the enzymes and ion channels datasets, we observe signiﬁcant
improvementswhenthemultitaskkernelisusedinplaceoftheDirac
kernel, on the one hand, and when the hierarchy kernel replaces
the multitask kernel, on the other hand. For example, the Dirac
kernel only performs at an averageAUC of 77% for the ion channel
dataset, while the multitask kernel increases the AUC to 87.3%
and the hierarchy kernel brings it to 92.5%. For the enzymes, a
global improvement of 30.9% is observed between the Dirac and
the hierarchy approaches. This clearly demonstrates the beneﬁts of
Table1. AUCfortheﬁrstprotocoloneachdatasetwithvarioustargetkernels
Ktar\ Target Enzymes GPCR Channels
Dirac 0.646±0.009 0.750±0.023 0.770±0.020
Multitask 0.931±0.006 0.749±0.022 0.873±0.015
Hierarchy 0.955±0.005 0.926±0.015 0.925±0.012
Mismatch 0.725±0.009 0.805±0.023 0.875±0.015
Local alignment 0.676±0.009 0.824±0.021 0.901±0.013
Fig. 2. Target kernel Gram matrices (Ktar) for ion channels with multitask,
hierarchy and local alignment kernels.
sharing information among known ligands of different targets, on
the one hand, and the relevance of incorporating prior information
into the kernels, on the other hand.
On the GPCR dataset though, the multitask kernel performs
slightly worse than the Dirac kernel, probably because some targets
in different subclasses show very different binding behavior, which
results in adding more noise than information when sharing naively
withthiskernel.However,amorecarefulhandlingofthesimilarities
between GPCRs through the hierarchy kernel results in signiﬁcant
improvement over the Dirac kernel (from 75% to 92.6%), again
demonstrating the relevance of the approach.
Sequence-based target kernels do not achieve the same
performance as the hierarchy kernel, although they perform
relativelywellfortheionchanneldataset,andgivebetterresultsthan
the multitask kernel for both GPCR and ion channel datasets. In the
case of enzymes, it can be explained by the diversity of the proteins
in the family and for the GPCR, by the well-known fact that the
receptors do not share overall sequence homology (Gether, 2000).
Figure 2 shows three of the tested target kernels for the ion channel
dataset. The hierarchy kernel adds some structure information with
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Fig. 3. Relative improvement of the hierarchy kernel against the Dirac kernel as a function of the number of known ligands for enzymes, GPCR and ion
channel datasets. Each point indicates the mean performance ratio between individual and hierarchy approaches across the targets of the family for which a
given (x-axis) number of training points was available.
respect to the multitask kernel, which explains the increase inAUC.
The local alignment sequence-based kernels fail to precisely rebuild
this structure but retain some substructures. In the cases of GPCR
and enzymes, almost no structure is found by the sequence kernels,
which, as alluded to above, was expected and suggests that more
subtle comparison of the sequences would be required to exploit the
information they contain.
Figure 3 illustrates the inﬂuence of the number of training points
for a target on the improvement brought by using information from
similar targets.As one could expect, the improvement is very strong
when few ligands are known and decreases when enough training
points become available. After a certain point (around 30 training
points), using similar targets can even impair the performances.This
suggests that the method could be globally improved by learning for
each target independently how much information should be shared,
for example, through kernel learning approaches (Lanckriet et al.,
2004).
The second experiment aims at pushing this remark to its limit by
assessing how each strategy is able to predict ligands for proteins
with no known ligand. Table 2 shows the results in that case. As
expected, the classiﬁers using Dirac kernels show random behavior
in this case since using a Dirac kernel with no data for the target
amounts to learning with no training data at all. In particular, in the
SVM implementation that we used, the classiﬁer learned with no
datafromthetaskgaveconstantscorestoallthetestpoints,hencethe
0.500±0.000AUC on the test data. On the other hand, we note that
it is still possible to obtain reasonable results using adequate target
kernels. In particular, the hierarchy kernel loses only 7.2% of AUC
for the ion channel dataset, 5.1% for the GPCR dataset and 1.7% for
the enzymes compared to the ﬁrst experiment where known ligands
were used, suggesting that if a target with no known compound is
placedinthehierarchy,e.g.inthecaseofGPCRhomologydetection
with known members of the family using speciﬁc GPCR alignment
algorithms(Kratochwiletal.,2005)orﬁngerprintanalysis(Attwood
et al., 2003), it is possible to predict some of its ligands almost as
accurately as if some of them were already available.
In this second setting, our approach when using the hierarchy
kernel on the targets is closely related to annotation transfer. Indeed,
the learned predictor in this case will predict a molecule to be a
ligand of a given target if the molecule is similar to the known
Table 2. AUC for the second protocol on each dataset with various target
kernels
Ktar\ Target Enzymes GPCR Channels
Dirac 0.500±0.000 0.500±0.000 0.500±0.000
Multitask 0.902±0.008 0.576±0.026 0.704±0.026
Hierarchy 0.938±0.006 0.875±0.020 0.853±0.019
Mismatch 0.602±0.008 0.703±0.027 0.729±0.024
Local alignment 0.535±0.005 0.751±0.025 0.772±0.023
ligands of close targets in the hierarchy. In particular, it will predict
that the ligands of the target’s direct neighbors are ligands of
the target (which is an intuitive and natural way to choose new
candidate binders). A major difference, however, is that a candidate
molecule which is very similar to ligands of a close target, but
not a ligand itself, will not be be predicted to be a ligand by the
annotation transfer approach. In particular, if the candidate molecule
is not present anywhere else in the ligand database, it will never
be predicted to be a ligand. Exemples can be found in each of
the considered target classes. The 4-aminopyridine is a blocker of
the ion channel KCJN5, a potassium inwardly rectifying channel.
Although this molecule is a known blocker of other channels (in
particular, many potassium channels), it is not a known ligand of
any other channel of KCJN5’s superfamily. However, the most
similar molecule in the database, in the sense of the Tanimoto
kernel, is the Pinacidil, which happens to be a known ligand of
two direct neighbors of KCJN5. This allows our method to predict
4-aminopyridine as a ligand for this target. Similarly, N-acetyl-
d-glucosamine 1,6-bisphosphate is the only known effector of
phosphoacetylglucosamine mutase, an enzyme of the isomerase
family. This molecule is not a known ligand of any other enzyme in
the database, so a direct annotation transfer approach would never
predict it as a ligand. Our method, on the other hand, predicts it
correctly, taking advantage of the fact that very similar molecules
like D-ribose 1,5-bisphosphate or α-d-glucose 1,6-bisphosphate are
known ligands of direct neighbors. The same observation can be
made for several GPCRs, including the prostaglandin F receptor
whose three known ligands are not ligands of any other GPCR but
whose direct neighbors have similar ligands.
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5 DISCUSSION
We propose a general method to combine the chemical and the
biological space in an algorithmic way and predict interaction
between any small molecule and any target, which makes it a very
valuabletoolfordrugdiscovery.Themethodallowsonetorepresent
systematically a ligand–target pair, including information on the
interaction between the ligand and the target. Prediction is then
performed by any machine learning algorithm (an SVM in our case)
in the joint space, which makes targets with few known ligands
beneﬁt from the data points of similar targets, and which allows
one to make predictions for targets with no known ligand. Our
information-sharing process is therefore simply based on a choice
of description for the ligands, another one for the targets and on
classical machine learning methods. Everything is done by casting
theprobleminajointspaceandnoexplicitproceduretoselectwhich
part of the information is shared is needed. Since it subdivides the
representation problem into two subproblems, our approach makes
useofpreviousworkonkernelsformoleculargraphsandkernelsfor
biological targets. For the same reason, it will automatically beneﬁt
from future improvements in both ﬁelds. This leaves plenty of room
to increase the performance.
Results on experimental ligand datasets show that using target
kernelsallowingtoshareinformationacrossthetargetsconsiderably
improve the prediction, especially in the case of targets with
few known ligands. The improvement is particularly strong
when the target kernel uses prior information on the structure
between the targets, e.g. a hierarchy deﬁned on a target class.
Although the usage of a kernel based on the hierarchy is restricted
to protein families where hierarchical classiﬁcation schemes exist,
it applies to the three main classes of proteins targeted by drugs, and
others like cytochromes and abc transporters. Sequence kernels, on
the other hand, did not give very good results in our experiments.
However, we believe using the target sequence information could be
an interesting alternative or complement to the hierarchy kernel. For
example, Jacob et al. (2008) used a kernel based on the sequence
of the GPCR that performed as well as the kernel based on the
GPCR hierarchy. Further improvement could come from the use of
kernel for structures in the cases where 3D structure information is
available (e.g. for the enzymes, but not for the GPCR). Our method
also shows good performances even when no ligand is known at all
for a given target, which is excellent news since classical ligand-
based approaches fail to predict ligand for these targets on the one
hand, and docking approaches are computationally expensive and
not feasible when the target 3D structure is unknown, which is the
case of GPCR on the other hand.
In future work, it could be interesting to apply this framework to
quantitative prediction of binding afﬁnity using regression methods
in the joint space. It would also be important to conﬁrm predicted
ligands experimentally or at least by docking approaches when the
target 3D structure is available.
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